Moshe Manor
2015
In 2015, Moshe Manor earned a total compensation of $858.4K as President and Chief Executive Officer at Protalix BioTherapeutics, a 174% increase compared to previous year.
Compensation breakdown
| Option Awards | $427,864 |
|---|---|
| Salary | $334,708 |
| Other | $95,823 |
| Total | $858,395 |
Manor received $427.9K in option awards, accounting for 50% of the total pay in 2015.
Manor also received $334.7K in salary and $95.8K in other compensation.
Rankings
In 2015, Moshe Manor's compensation ranked 8,672nd out of 13,638 executives tracked by ExecPay. In other words, Manor earned more than 36.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,672 out of 13,638 | 36th |
Division Manufacturing | 3,314 out of 5,187 | 36th |
Major group Chemicals And Allied Products | 1,210 out of 1,857 | 35th |
Industry group Drugs | 984 out of 1,531 | 36th |
Industry Biological Products, Except Diagnostic Substances | 171 out of 260 | 34th |
Source: SEC filing on March 16, 2017.
Manor's colleagues
We found four more compensation records of executives who worked with Moshe Manor at Protalix BioTherapeutics in 2015.
2015
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2015
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2015
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2015
Tzvi Palash
Protalix BioTherapeutics